Risk factors for bacteriuria due to Pseudomonas aeruginosa or Enterococcus spp in patients hospitalized via the emergency department

  • D. Raveh
  • I. Rosenzweig
  • B. Rudensky
  • Y. Wiener-Well
  • A. M. Yinnon
Concise Article


To determine the incidence and risk factors related to isolation of Pseudomonas aeruginosa or Enterococcus spp from urine cultures obtained from patients in the emergency department (ED), a 1-year prospective study was conducted of all urine specimens collected in the ED of a general hospital. Specimens from which one of these organisms was isolated at a concentration of ≥105 cfu/ml were included. Of 744 positive urine cultures, 39 (5%) were P. aeruginosa and 28 (4%) Enterococcus spp. Comparison with a control cohort of 80 patients with Escherichia coli bacteriuria revealed several univariate indicators for P. aeruginosa bacteriuria, including male sex, indwelling catheter, past prostatectomy, hospitalization in the previous 2 months and pregnancy; multivariate indicators were indwelling catheter (p<0.001) and male sex (p<0.001). Enterococcus and P. aeruginosa were significantly more often associated with asymptomatic bacteriuria. These data will help clinicians select appropriate antibiotic treatment for patients with urinary tract infections.


urinary tract infection asymptomatic bacteriuria Pseudomonas Enterococcus empiric antibiotic treatment 


  1. 1.
    Stamm WE (2002) Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113(Suppl 1A):1–4CrossRefGoogle Scholar
  2. 2.
    Raveh D, Rudensky B, Huerta M, Aviv Y, Yinnon AM (2003) An improved, evidence-based method for empirical treatment of urinary tract infection. Eur J Clin Microbiol Infect Dis 22:158–164PubMedGoogle Scholar
  3. 3.
    Gilbert DN (2005) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. 6th edn. Churchill Livingstone, Philadelphia pp 328–356Google Scholar
  4. 4.
    Roberts JA (1999) Management of pyelonephritis and upper urinary tract infections. Urol Clin North Am 26:753–763PubMedCrossRefGoogle Scholar
  5. 5.
    Clarridge JE, Johnson JR, Pezzlo MT (1998) Cumitech 2B, Laboratory diagnosis of urinary tract infections. Coordinating ed. Weissfeld AS. American Society for Microbiology, Washington, District of ColumbiaGoogle Scholar
  6. 6.
    Rosenberg M, Berger SA, Barki M, Goldberg S, Fink A, Miskin A (1992) Initial testing of a novel urine culture device. J Clin Microbiol 30:2686–2691PubMedGoogle Scholar
  7. 7.
    Raz R, Okev N, Kennes Y, Gilboa A, Lavi I, Bisharat N (2000) Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J 2:426–429PubMedGoogle Scholar
  8. 8.
    Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB (1999) Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 44:359–365PubMedCrossRefGoogle Scholar
  9. 9.
    Bishara J, Leibovici L, Huminer D, Drucker M, Samra Z, Konigsberger H, Pitlik S (1997) Five year prospective study of bacteraemic urinary tract infection in a single institution. Eur J Clin Microbiol Infect Dis 16:563–567PubMedCrossRefGoogle Scholar
  10. 10.
    Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P (1997) Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel. Eur J Clin Microbiol Infect Dis 16:834–838PubMedCrossRefGoogle Scholar
  11. 11.
    Huang YC, Lin TY, Wang CH (2002) Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes. Pediatr Infect Dis J 21:1049–1052PubMedCrossRefGoogle Scholar
  12. 12.
    Pier GB, Ramphal R (2005) Pseudomonas aeruginosa. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases. 6th edn. Churchill Livingstone, Philadelphia pp 2587–2615Google Scholar
  13. 13.
    Lloyd S, Zervos M, Mahayni R, Lundstrom T (1998) Risk factors for enterococcal urinary tract infection and colonization in a rehabilitation facility. Am J Infect Control 26:35–39PubMedCrossRefGoogle Scholar
  14. 14.
    Raveh D, Rudensky D, Schlesinger Y, Attias D, Yinnon AM (2003) Trends in bacteremias: analysis of 7544 patient-specific bacteremic episodes spanning 11 years (1990–2000). J Hosp Infect 55:196–203PubMedCrossRefGoogle Scholar
  15. 15.
    Raveh D, Koppitt R, Hite Y, Rudensky B, Sonnenblick M, Yinnon AM (2002) Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Quart J Med 95:291–297Google Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • D. Raveh
    • 1
    • 2
  • I. Rosenzweig
    • 1
    • 2
  • B. Rudensky
    • 2
    • 3
  • Y. Wiener-Well
    • 1
    • 2
  • A. M. Yinnon
    • 1
    • 4
  1. 1.Infectious Diseases UnitShaare Zedek Medical CenterJerusalemIsrael
  2. 2.Faculty of Health SciencesBen Gurion University of the NegevBe’er-ShevahIsrael
  3. 3.Clinical Microbiology LaboratoryShaare Zedek Medical CenterJerusalemIsrael
  4. 4.Hebrew University-Hadassah Medical SchoolJerusalemIsrael

Personalised recommendations